| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 43 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 6, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 30,000 | $40.93 | $1,227,776.34 | -0.6% | |
| Nov 21, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $39.37 | $1,560,288.06 | -0.4% | |
| Nov 15, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $39.77 | $159,094.00 | -7.7% | |
| Nov 15, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $39.24 | $39,240.00 | -3.0% | |
| Nov 2, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $44.32 | $1,756,621.42 | -0.4% | |
| Oct 19, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $54.22 | $2,148,925.68 | -0.2% | |
| Oct 18, 2018 | Kurkijarvi Kalevi | Director | Sale+OE | 4,000 | $55.42 | $221,670.00 | -7.3% | |
| Oct 18, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $55.39 | $55,387.28 | -1.5% | |
| Oct 3, 2018 | Neff Thomas B | Chief Executive Officer | Sale+OE | 39,636 | $59.15 | $2,344,297.99 | -0.4% | |
| Sep 20, 2018 | Rosenkranz Roberto Pedro | Director | Sale+OE | 1,000 | $56.95 | $56,950.00 | -3.0% |